Focal liver steatosis as a complication of pancreatic islet cell transplantation in diabetes mellitus
- Authors: Bersenev A.V.
- Issue: Vol 1, No 3 (2006)
- Pages: 26-26
- Section: Cell technology
- URL: https://genescells.ru/2313-1829/article/view/256775
- DOI: https://doi.org/10.23868/gc256775
- ID: 256775
Cite item
Open Access
Access granted
Full Text
About the authors
A. V. Bersenev
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation
References
- Ryan E.A., Paty B.W., Senior P.A. et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54[7): 2060-9.
- Brennan D.C., Shannon M.B., Koch M.J. et al. Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation 2004; 78(1): 172-3.
- Ryan E.A., Paty B.W., Senior P.A., Shapiro A.M. Risks and side effects of islet transplantation. Curr. Diab. Rep. 2004; 4(4): 304-9.
- Markmann J.F., Rosen M., Siegelman E.S. et al. Magnetic resonance- defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes 2003; 52(7): 1591 -4.
- Bhargava R., Senior P.A., Ackerman T.E. et al. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 2004; 53(5): 1311-7.
- Maffi P., Bertuzzi F., Angeli E. et al. Imaging and histological changes of liver after intraportal islet transplantation (abstract). Cell Transplant. 2003; 12: 156.
Supplementary files
